Inogen Inc (INGN)
9.21
-0.25
(-2.64%)
USD |
NASDAQ |
Nov 21, 16:00
9.22
+0.01
(+0.11%)
After-Hours: 20:00
Inogen Enterprise Value: 98.70M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 98.70M |
| November 20, 2024 | 104.66M |
| November 19, 2024 | 105.37M |
| November 18, 2024 | 106.09M |
| November 15, 2024 | 118.71M |
| November 14, 2024 | 116.33M |
| November 13, 2024 | 125.38M |
| November 12, 2024 | 128.00M |
| November 11, 2024 | 141.82M |
| November 08, 2024 | 143.48M |
| November 07, 2024 | 104.66M |
| November 06, 2024 | 107.28M |
| November 05, 2024 | 99.42M |
| November 04, 2024 | 94.42M |
| November 01, 2024 | 86.32M |
| October 31, 2024 | 87.27M |
| October 30, 2024 | 100.13M |
| October 29, 2024 | 102.27M |
| October 28, 2024 | 100.48M |
| October 25, 2024 | 99.17M |
| October 24, 2024 | 99.89M |
| October 23, 2024 | 98.22M |
| October 22, 2024 | 98.22M |
| October 21, 2024 | 96.08M |
| October 18, 2024 | 104.89M |
| Date | Value |
|---|---|
| October 17, 2024 | 99.41M |
| October 16, 2024 | 102.75M |
| October 15, 2024 | 99.65M |
| October 14, 2024 | 97.98M |
| October 11, 2024 | 93.46M |
| October 10, 2024 | 91.31M |
| October 09, 2024 | 93.70M |
| October 08, 2024 | 98.22M |
| October 07, 2024 | 97.51M |
| October 04, 2024 | 96.55M |
| October 03, 2024 | 99.65M |
| October 02, 2024 | 105.13M |
| October 01, 2024 | 108.46M |
| September 30, 2024 | 110.37M |
| September 27, 2024 | 112.15M |
| September 26, 2024 | 113.57M |
| September 25, 2024 | 122.82M |
| September 24, 2024 | 122.47M |
| September 23, 2024 | 125.43M |
| September 20, 2024 | 130.65M |
| September 19, 2024 | 137.29M |
| September 18, 2024 | 135.63M |
| September 17, 2024 | 139.43M |
| September 16, 2024 | 142.51M |
| September 13, 2024 | 151.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-50.93M
Minimum
Sep 25 2023
1.610B
Maximum
Aug 04 2021
453.94M
Average
403.84M
Median
Sep 08 2022
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| ResMed Inc | 36.01B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.963M |
| Revenue (Quarterly) | 88.83M |
| Total Expenses (Quarterly) | 96.63M |
| EPS Diluted (Quarterly) | -0.25 |
| Gross Profit Margin (Quarterly) | 46.54% |
| Profit Margin (Quarterly) | -6.71% |
| Earnings Yield | -24.43% |
| Normalized Earnings Yield | -24.43 |